.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, Sector 18, Rohini, New Delhi -110085
ADJ
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

SWASTHFIT COMPLETE PACKAGE

HEMOGRAM

Hemoglobin 11.90 g/dL 12.00 - 15.00

(Photometry)
Packed Cell Volume (PCV) 36.00 % 36.00 - 46.00
(Calculated)
RBC Count 4.09 mill/mm3 3.80 - 4.80
(Electrical Impedence)
MCV 88.10 fL 83.00 - 101.00
(Electrical Impedence)
MCH 29.00 pg 27.00 - 32.00
(Calculated)
MCHC 32.90 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 13.60 % 11.60 - 14.00
(Electrical Impedence)
Total Leukocyte Count (TLC) 5.80 thou/mm3 4.00 - 10.00
(Electrical Impedence)
Differential Leucocyte Count (DLC)
(VCS Technology)
Segmented Neutrophils 51.70 % 40.00 - 80.00
Lymphocytes 35.20 % 20.00 - 40.00
Monocytes 9.40 % 2.00 - 10.00
Eosinophils 3.40 % 1.00 - 6.00
Basophils 0.30 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 3.00 thou/mm3 2.00 - 7.00
Lymphocytes 2.04 thou/mm3 1.00 - 3.00
Monocytes 0.55 thou/mm3 0.20 - 1.00
Eosinophils 0.20 thou/mm3 0.02 - 0.50
Basophils 0.02 thou/mm3 0.02 - 0.10

Platelet Count 132 thou/mm3 150.00 - 410.00

(Electrical impedence)
Mean Platelet Volume 13.8 fL 6.5 - 12.0
(Electrical Impedence)

*460859297* Page 1 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, Sector 18, Rohini, New Delhi -110085
ADJ
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

E.S.R. 10 mm/hr 0.00 - 20.00
(Capillary photometry)

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

*460859297* Page 2 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

LIVER & KIDNEY PANEL, SERUM

Creatinine 0.73 mg/dL 0.55 - 1.02

(Modified Jaffe,Kinetic)
GFR Estimated 102 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea 21.20 mg/dL 13.00 - 43.00
(Urease UV)
Urea Nitrogen Blood 9.90 mg/dL 6.00 - 20.00
(Calculated)
BUN/Creatinine Ratio 14
(Calculated)
Uric Acid 2.60 mg/dL 2.60 - 6.00
(Uricase)
AST (SGOT) 18.0 U/L 13.00 - 35.00
(IFCC without P5P)
ALT (SGPT) 12.0 U/L 10.00 - 49.00
(IFCC without P5P)
GGTP 13.0 U/L 0 - 38
(IFCC)
Alkaline Phosphatase (ALP) 67.00 U/L 30.00 - 120.00
(IFCC-AMP)
Bilirubin Total 0.62 mg/dL 0.30 - 1.20
(Oxidation)
Bilirubin Direct 0.19 mg/dL <0.3
(Oxidation)
Bilirubin Indirect 0.43 mg/dL <1.10
(Calculated)
Total Protein 7.40 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.57 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.61 0.90 - 2.00
(Calculated)
Globulin(Calculated) 2.83 gm/dL 2.0 - 3.5

Calcium, Total 9.20 mg/dL 8.70 - 10.40

(Arsenazo III)

*460859297* Page 3 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 3.60 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 143.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 4.68 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 108.00 mEq/L 98.00 - 107.00
(Indirect ISE)

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

LIPID SCREEN, SERUM

Cholesterol, Total 175.00 mg/dL <200.00

(CHO-POD)
Triglycerides 125.00 mg/dL <150.00
(GPO-POD)
HDL Cholesterol 41.00 mg/dL >50.00
(Enz Immunoinhibition)
LDL Cholesterol, Calculated 109.00 mg/dL <100.00
(Calculated)
VLDL Cholesterol,Calculated 25.00 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 134 mg/dL <130
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
3. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for

*460859297* Page 4 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
4. Indians tend to have higher triglyceride levels & Lower HDL cholesterol combined with small dense
LDL particles, a pattern known as atherogenic dyslipidemia
5. Non HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL,
VLDL & VLDL remnants, Chylomicron remnants & Lp(a)
6. LAI recommends LDL cholesterol as primary target and Non HDL cholesterol as co-primary treatment
target
7. Apolipoprotein B is an, secondary lipid target for treatment once LDL & Non HDL goals have been
achieved
8. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered among
patients with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at
least 3 months

*460859297* Page 5 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, Sector 18, Rohini, New Delhi -110085
ADJ
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 5.2 % 4.00 - 5.60

Estimated average glucose (eAG) 103 mg/dL

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*460859297* Page 6 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 93.00 mg/dL 70 - 100

(GOD POD)

AMYLASE, SERUM 101.00 U/L 30.00 - 118.00

(G7PNP)
Comments
Amylase is produced in the Pancreas and most of the elevation in serum is due to increased rate of Amylase
entry into the blood stream / decreased rate of clearance or both. Serum Amylase rises within 6 to 48 hours
of onset of Acute pancreatitis in 80% of patients, but is not proportional to the severity of the disease. Activity
usually returns to normal in 3-5 days in patients with milder edematous form of the disease. Values persisting
longer than this period suggest continuing necrosis of pancreas or Pseudocyst formation. Approximately 20%
of patients with Pancreatitis have normal or near normal activity. Hyperlipemic patients with Pancreatitis also
show spuriously normal Amylase levels due to suppression of Amylase activity by triglyceride. Low Amylase
levels are seen in Chronic Pancreatitis, Congestive Heart failure, 2nd & 3rd trimesters of pregnancy,
Gastrointestinal cancer & bone fractures.

CARDIO C-REACTIVE PROTEIN (hsCRP), SERUM 0.90 mg/L <1.00

(Immunoturbidimetry)
Interpretation
--------------------------------------------------------------
| CARDIO CRP IN mg/L | CARDIOVASCULAR RISK |
|-----------------------|--------------------------------------|
| <1 | Low |
|-----------------------|--------------------------------------|
| 1-3 | Average |
|-----------------------|--------------------------------------|
| 3-10 | High |
|-----------------------|--------------------------------------|
| >10 | Persistent elevation may represent |
| | Non cardiovascular inflammation |
--------------------------------------------------------------
Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and
calculate the average

Comments
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a
strongest predictor of future coronary events. It reveals the risk of future Myocardial infarction and Stroke
among healthy men and women, independent of traditional risk factors. It identifies patients at risk of first
Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events also
correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident
Diabetes.

*460859297* Page 7 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

APOLIPOPROTEINS A1 & B, SERUM

(Immunoturbidimetry)

Apolipoprotein (Apo A1) 107 mg/dL 76 - 214

Apolipoprotein (Apo B) 86 mg/dL 46 - 142

Apo B / Apo A1 Ratio 0.80 0.35 - 0.98

Comments
Apolipoprotein B is a more powerful independent predictor of Coronary Heart Disease (CAD) than LDL
Cholesterol. It is useful in assessing the risk of CAD and to classify Hyperlipidemias. Apolipoprotein studies
help in monitoring coronary bypass surgery patients with regard to risk and severity of re -stenosis. They are
also useful in assessing risk of re-infarction in patients of Myocardial infarction.

Apolipoprotein A1 is one of the apoproteins of high density lipoproteins (HDL) which is inversely related to the
risk of CAD. Individuals with Tangier disease have < 1% of normal Apo A1. Levels <90mg/dL indicate
increased risk of Atherosclerotic disease.

As per recommendations of National Cholesterol Education Program (NCEP) the clinical

significance of results is as follows:
Apolipoprotein B
-----------------------------------------------------------------------------
| RESULT IN mg/dL | REMARKS |
|--------------------------|-------------------------------------------------|
| <23 |Abetalipoproteinemia/Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 23-45 |Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 46-135 |Normal |
| -------------------------|-------------------------------------------------|
| >135 |Hyperapobetalipoproteinemia/Increased CAD risk |
--------------------------|-------------------------------------------------
Apo B to A1 Ratio
-------------------------------
| RATIO | REMARKS |
|------------|------------------|
| 0.35-0.98 | Desirable |
|------------|------------------|
| >0.98 |Increased CAD risk|
-------------------------------

*460859297* Page 8 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

VITAMIN B12; CYANOCOBALAMIN, SERUM 219.00 pg/mL 211.00 - 911.00
(CLIA)
Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

VITAMIN D, 25 - HYDROXY, SERUM 56.19 nmol/L 75.00 - 250.00

(CLIA)
Interpretation
-------------------------------------------------------------
| LEVEL | REFERENCE RANGE | COMMENTS |
| | IN nmol/L | |
|---------------|-----------------|---------------------------|
| Deficient | < 50 | High risk for developing |
| | | bone disease |
|---------------|-----------------|---------------------------|
| Insufficient | 50-74 | Vitamin D concentration |
| | | which normalizes |
| | | Parathyroid hormone |
| | | concentration |
|---------------|-----------------|---------------------------|
| Sufficient | 75-250 | Optimal concentration |
| | | for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential | >250 | High risk for toxic |
| intoxication | | effects |
-------------------------------------------------------------

Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.

*460859297* Page 9 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

Comments
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).

Decreased Levels
· Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome

Increased levels
Vitamin D intoxication

*460859297* Page 10 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, Sector 18, Rohini, New Delhi -110085
ADJ
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

IRON STUDIES, SERUM

(Spectrophotometry)
Iron 59.00 ug/dL 50.00 - 170.00

Total Iron Binding Capacity (TIBC) 289.00 µg/dL 250 - 425

Transferrin Saturation 20.42 % 15.00 - 50.00

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

THYROID PROFILE,TOTAL, SERUM

(CLIA)
T3, Total 1.65 ng/mL 0.60 - 1.81

T4, Total 10.80 µg/dL 5.01 - 12.45

TSH 4.07 µIU/mL 0.550 - 4.780

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate

*460859297*
Page 11 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, Sector 18, Rohini, New Delhi -110085
ADJ
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in some
individuals

Interpretation
---------------------------------------------------------------
| PREGNANCY | REFERENCE RANGE FOR TSH IN µIU/mL |
| | (As per American Thyroid Association) |
|--------------------|------------------------------------------|
| 1st Trimester | 0.100 - 2.500 |
| | |
| 2nd Trimester | 0.200 - 3.000 |
| | |
| 3rd Trimester | 0.300 - 3.000 |
---------------------------------------------------------------

*460859297*
Page 12 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)

Physical

Colour Light Yellow Pale yellow

Specific Gravity <=1.005 1.001 - 1.030

pH 7 5.0 - 8.0

Chemical

Proteins Negative Negative

Glucose Negative Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

Microscopy

R.B.C. Negative 0.0 - 2.0 RBC/hpf

Pus Cells Negative 0-5 WBC / hpf

Epithelial Cells 0-1 Epi Cells/hpf 0.0 - 5.0 Epi

cells/hpf
Casts None seen None seen/Lpf

Crystals None seen None seen

Others None seen None seen

*460859297*
Page 13 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Shalabh Malik

MD, Biochemistry MD, Biochemistry MD, Pathology MD, Microbiology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Technical Director - Microbiology,
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Infectious Disease Molecular &
NRL - Dr Lal PathLabs Ltd Serology, Clinical Pathology
NRL - Dr Lal PathLabs Ltd

Dr Sunanda
MD, Pathology
Sr. Consultant Pathologist -
Hematology & Immunology
NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKIBACAMOHBMKINKAKPEFLFCNKKNCFLOFOCJOPAHEEEHA
BNFFFNBPAOFHIGEOALBDEDFHAHFHACEHMGIGAOJPMDAOMPBNFFFNB
GPFAACFPJNFNMACOFKDKIGJOGABFDCIKMFPCBNFBOKKKMLECFGHOL
CJFOPNFJIOMAMGCGEAKEDLPGMPHELFCIKMHOFNMFOMCHFKNODGFCG
PAJOGIFLHCLLHBBJHNKEHCIMCGHDCJKAOOPIBKPJKEDGHKFPGKPCH
MDNCFBFMEIEGIMBJJKGCKKEGBGDCMECNOONEDCOHKLBAENFEBIPKO
EOMCAHFHAFIDPBPMNLDPCKLIAHFHAKBFNLNICKFFOECNAHFHACPHK
FGKPDDFGABGGDAGDHAHAHJPCGFEFBLADLCECBNFFOBDGCFCFBHDDK
CFCADIFKGOJLKMLNAMKABPPDFEFFPDKDKKNKBMMBKNCIBACDIFHGC
MLNGGAFGOGGKNINACALGIFLDIPLCFHKHPLFNBCHPINDPKBOEKEHCP
NIKBNJFEPAEGJNOIGKHDJEOKPLIFFNLHKFNDAIENLLDOLFGIKPLNL
MNNFNNEHCEIACGIAEGNAOKIDAHFHAFKGNKFCBLNPOBAIAHFHACHPL
APBBBPAPBALONHHCOKIJFLELBCHCBCAHOGMIBNNBOLCCDHHCFABAJ
HHHHHHHPHPHHHPHHPPHHPHHHHHPHPPHHPPPPHPPHPHHPPHPPHPHPP

*460859297*
Page 14 of 15
.

Name : Ms. LAKSHMI JHA

Lab No. : 460859297 Age : 46 Years
Ref By : SELF Gender : Female
Collected : 16/2/2024 9:00:00AM Reported : 16/2/2024 5:37:42PM
A/c Status : P Report Status : Final
Collected at : PSC-MUKHERJEE NGR. Processed at : LPL-NATIONAL REFERENCE LAB
A - 37,38,39, GROUND FLOOR, GF - 2, COMM National Reference laboratory, Block E,
ERCIAL COMPLEX, DR. MUKHERJEE NAGAR, ADJ Sector 18, Rohini, New Delhi -110085
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

*460859297*
Page 15 of 15